Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity

J Med Chem. 2019 May 9;62(9):4624-4637. doi: 10.1021/acs.jmedchem.9b00212. Epub 2019 Apr 19.

Abstract

Various mechanisms for regulated cell death include the formation of oxidative mediators such as lipid peroxides and nitric oxide (NO). In this respect, 15-lipoxygenase-1 (15-LOX-1) is a key enzyme that catalyzes the formation of lipid peroxides. The actions of these peroxides are interconnected with nuclear factor-κB signaling and NO production. Inhibition of 15-LOX-1 holds promise to interfere with regulated cell death in inflammatory conditions. In this study, a novel potent 15-LOX-1 inhibitor, 9c (i472), was developed and structure-activity relationships were explored. In vitro, this inhibitor protected cells from lipopolysaccharide-induced cell death, inhibiting NO formation and lipid peroxidation. Thus, we provide a novel 15-LOX-1 inhibitor that inhibits cellular NO production and lipid peroxidation, which set the stage for further exploration of these mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonate 15-Lipoxygenase / chemistry
  • Arachidonate 15-Lipoxygenase / metabolism
  • Catalytic Domain
  • Gene Expression / drug effects
  • Indoles / chemical synthesis
  • Indoles / metabolism
  • Indoles / pharmacology*
  • Lipid Peroxidation / drug effects
  • Lipopolysaccharides / pharmacology
  • Lipoxygenase Inhibitors / chemical synthesis
  • Lipoxygenase Inhibitors / metabolism
  • Lipoxygenase Inhibitors / pharmacology*
  • Mice
  • Molecular Docking Simulation
  • Molecular Structure
  • NF-kappa B p50 Subunit / antagonists & inhibitors
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / genetics
  • Oxidative Stress / drug effects
  • Protective Agents / chemical synthesis
  • Protective Agents / metabolism
  • Protective Agents / pharmacology*
  • Protein Binding
  • RAW 264.7 Cells
  • Rabbits
  • Signal Transduction / drug effects
  • Structure-Activity Relationship

Substances

  • Indoles
  • Lipopolysaccharides
  • Lipoxygenase Inhibitors
  • NF-kappa B p50 Subunit
  • Protective Agents
  • Nfkb1 protein, mouse
  • Nitric Oxide
  • Arachidonate 15-Lipoxygenase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse